Label: OLOPATADINE solution/ drops

  • NDC Code(s): 70069-017-01
  • Packager: Somerset Therapeutics, LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated March 25, 2024

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENT

  • PURPOSE

    Drug Facts

    Active Ingredients
    Purpose
    Olopatadine (0.1%)
    (equivalent to olopatadine
    hydrochloride 0.111%)
    Antihistamine and Redness Reliever

  • INDICATIONS & USAGE

    Use temporarily relieves itchy and red eyes due to pollen, ragweed, grass, animal hair and dander

  • WARNINGS

    Warnings

    For external use only

    Do not use

    • if solution changes color or becomes cloudy
    • if you are sensitive to any ingredient in this product
    • to treat contact lens related irritation

    When using this product

    • do not touch tip of container to any surface to avoid contamination
    • remove contact lenses before use
    • wait at least 10 minutes before reinserting contact lenses after use
    • do not wear a contact lens if your eye is red

    Stop use and ask a doctor if you experience:

    • eye pain
    • changes in vision
    • increased redness of the eye
    • itching worsens or lasts for more than 72 hours

    Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

  • DOSAGE & ADMINISTRATION

    Directions

    • adults and children 2 years of age and older:
    • put 1 drop in the affected eye(s) twice daily, every 6 to 8 hours, no more than twice per day
    • if using other ophthalmic products while using this product, wait at least 5 minutes between each product
    • replace cap after each use
    • children under 2 years of age: consult a doctor
  • STORAGE AND HANDLING

    Other information

    • only for use in the eye
    • store between 4°-25°C (39°-77°F)
  • INACTIVE INGREDIENT

    Inactive ingredients

    benzalkonium chloride 0.01%, dibasic sodium phosphate, hydrochloric acid/sodium hydroxide (adjust pH), sodium chloride and water for injection

  • QUESTIONS

    Questions?

    Customer Care # 1-800-417-9175

  • SPL UNCLASSIFIED SECTION

    Manufactured for:

    Somerset Therapeutics, LLC

    Somerset, NJ 08873

    Made in India

    Code No.:KR/DRUGS/KTK/28/289/97

    ST-OLP11-OTC/P/01

    1200809

  • PRINCIPAL DISPLAY PANEL

    Container Label

     

    NDC 70069-017-01

    Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1%

    Antihistamine and Redness Reliever

    TWICE DAILY RELIEF

    Eye Allergy Itch & Redness Relief

    Sterile

    5 mL (0.017 FL OZ)

    Image

    Carton Label

     

    Original Prescription Strength

    NDC 70069-017-01

    Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1%

    Antihistamine and Redness Reliever

    TWICE DAILY RELIEF

    Eye Allergy Itch & Redness Relief

    TWICE DAILY

    Works in Minutes

    Relief from Allergens:

    • Pet Dander

    • Pollen

    • Grass

    • Ragweed

     

    Sterile

    5 mL (0.017 FL OZ

    Image
  • INGREDIENTS AND APPEARANCE
    OLOPATADINE 
    olopatadine solution/ drops
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70069-017
    Route of AdministrationOPHTHALMIC
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    OLOPATADINE HYDROCHLORIDE (UNII: 2XG66W44KF) (OLOPATADINE - UNII:D27V6190PM) OLOPATADINE1 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM PHOSPHATE, DIBASIC (UNII: GR686LBA74)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
    HYDROCHLORIC ACID (UNII: QTT17582CB)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:70069-017-011 in 1 CARTON04/15/2024
    15 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20630604/15/2024
    Labeler - Somerset Therapeutics, LLC (079947873)
    Registrant - Somerset Therapeutics, LLC (079947873)
    Establishment
    NameAddressID/FEIBusiness Operations
    Somerset Therapeutics Limited677236695ANALYSIS(70069-017) , LABEL(70069-017) , PACK(70069-017) , MANUFACTURE(70069-017)